Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Stubbs

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|September 12, 2017
Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML)Matthew C Stubbs, Andrei V Krivtsov
Oncogene|May 29, 2002
The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cellsMatthew C Stubbs, David J Hall
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Therapeutic implications of leukemia stem cell developmentMatthew C Stubbs, Scott A Armstrong
Current Drug Targets|June 23, 2007
FLT3 as a therapeutic target in childhood acute leukemiaMatthew C Stubbs, Scott A Armstrong
Blood|December 6, 2008
HOXA9 is required for survival in human MLL-rearranged acute leukemiasJoerg Faber, Andrei V Krivtsov, Matthew C Stubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2015
Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALLMatthew C Stubbs, Wonil Kim, Megan Bariteau, et al.
Blood Advances|November 15, 2019
The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPNLucia Mazzacurati, Robert J Collins, Garima Pandey, et al.
Gene|May 19, 2020
Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemiaGretchen Johnston, Haley E Ramsey, Qi Liu, et al.
Nature|July 25, 2006
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9Andrei V Krivtsov, David Twomey, Zhaohui Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid LeukemiaHaley E Ramsey, Dalton Greenwood, Susu Zhang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|September 12, 2017
Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML)Matthew C Stubbs, Andrei V Krivtsov
Oncogene|May 29, 2002
The amino-terminus of the E2F-1 transcription factor inhibits DNA replication of autonomously replicating plasmids in mammalian cellsMatthew C Stubbs, David J Hall
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Therapeutic implications of leukemia stem cell developmentMatthew C Stubbs, Scott A Armstrong
Current Drug Targets|June 23, 2007
FLT3 as a therapeutic target in childhood acute leukemiaMatthew C Stubbs, Scott A Armstrong
Blood|December 6, 2008
HOXA9 is required for survival in human MLL-rearranged acute leukemiasJoerg Faber, Andrei V Krivtsov, Matthew C Stubbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2015
Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALLMatthew C Stubbs, Wonil Kim, Megan Bariteau, et al.
Blood Advances|November 15, 2019
The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPNLucia Mazzacurati, Robert J Collins, Garima Pandey, et al.
Gene|May 19, 2020
Nascent transcript and single-cell RNA-seq analysis defines the mechanism of action of the LSD1 inhibitor INCB059872 in myeloid leukemiaGretchen Johnston, Haley E Ramsey, Qi Liu, et al.
Nature|July 25, 2006
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9Andrei V Krivtsov, David Twomey, Zhaohui Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2020
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid LeukemiaHaley E Ramsey, Dalton Greenwood, Susu Zhang, et al.
Pageof 2